CrossrefInfokarte
Concurrent RUNX1::MECOM and RUNX1::PRDM16 Fusions from a Novel Genomic Breakpoint: First Report of a Dual-Fusion Mechanism in Acute Myeloid Leukemia
OncoTargets and Therapy · 2026-09 · Volume 19 · 1-8
DOI: 10.2147/ott.s635500 ↗Abstract
Kein Abstract verfügbar.
EUVIMED